Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
about
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's DiseaseRisperidone treatment of drug-related psychosis in patients with parkinsonismReview of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.Pathophysiology and treatment of psychosis in Parkinson's disease: a review.Parkinson's psychosis.The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.Atypical antipsychotics in Parkinson-sensitive populations.New wine in old bottle: late-life psychosisAn update expert opinion on management and research strategies in Parkinson's disease psychosisBehavioral disturbances in Parkinson's diseaseThe management of psychosis in movement disorder patients.Management of the behavioral aspects of Parkinson's disease.Atypical antipsychotic drugs in the treatment of Parkinson's disease.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.Pharmacologic treatment of agitation in dementia: a comprehensive review.New dimensions in the pharmacologic treatment of schizophrenia and related psychoses.Risperidone in Parkinson's disease.Risperidone and Parkinson's disease.Risperidone in chorea and psychosis of Huntington's disease.Therapeutic dilemma: psychosis and Parkinson's disease.Late (Complicated) Parkinson's Disease
P2860
Q26738456-C3799F92-2C09-40B9-A315-DC8E620A83AAQ28375634-F7812C95-B1D3-473D-974C-0C1DC4BB184CQ33260251-FBCF08C5-2BFC-444B-B262-4AA7C7B95356Q33884378-1F0B8D02-FC04-4E14-8C64-71E108881756Q34610608-3D207A88-B406-44D8-88D2-F20A1148F70AQ34610632-B650A47B-D6EC-445E-A52A-CFD4D25ABC61Q34811957-9F4A8ADC-DB00-4D4A-A19C-33260DDFAFB6Q34851726-223B9CF5-1F54-4B23-B3A0-37B15FC926ABQ34976609-98C1E678-1926-45B0-AF9B-D956C302C028Q35154278-35AD6E6C-329E-4778-B4F1-57960E726105Q35236819-D6237DAD-ACD4-4FB2-A718-93D67EB20156Q36808034-131C70A5-E89C-448E-96E5-A6E69D56858EQ36847271-86EE38AC-81A9-4CE0-A365-EE66A75FBC76Q37957772-D64677B4-DF3A-4FE6-A40C-FEB3763D480EQ38070888-2245FD74-7EB5-4E2C-819E-9A51CDE92A8BQ38662579-AC2EF84B-6357-4C77-9F2C-1513FFD8BDC2Q41169288-6CF13702-9CE7-4DE0-B077-3EF79D196566Q41475059-DE3ED51E-BBF7-486C-9A84-ED8B2FD8E8A3Q42005474-6735CF6A-AC1F-4BE5-9205-05D0FE21ABACQ43880984-A59892A8-88BB-46CB-8A7D-7380CE17DCC0Q43907864-A73A1B28-01D0-4528-ACD6-A986C0E07297Q51119519-496A5A04-5E98-4F69-9029-6496E6074B5BQ58870320-2E60C4D5-9F38-4DDB-A44C-3ACB0CF99F5A
P2860
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@en
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@nl
type
label
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@en
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@nl
prefLabel
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@en
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@nl
P2093
P921
P1433
P1476
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
@en
P2093
A Alessandria
P Giustini
V Bonifati
P304
P356
10.1016/S0140-6736(94)92511-9
P407
P577
1994-05-01T00:00:00Z